Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study

Pignata, S.; Scambia, G.; Bologna, A.; Signoriello, S.; Vergote, I. B.; Wagner, U.; Lorusso, D.; Murgia,; Sorio, R.; Ferrandina, G.; Sacco, C.; Cormio, G.; Breda, E.; Cinieri, S.; Natale, D.; Mangili, G.; Pisano, C.; Cecere, S. C.; Di Napoli, M.; Salutari,; Raspagliesi, F.; Arenare, L.; Bergamini, A.; Bryce, J.; Daniele, G.; Piccirillo, M. C.; Gallo, C.; Perrone, F.

Links

ORCID

Tools

Export citation

Search in Google Scholar

Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study

Journal article published in 2017 by S. Pignata, G. Scambia, A. Bologna, S. Signoriello, I. B. Vergote, U. Wagner, D. Lorusso, Murgia, R. Sorio, G. Ferrandina, C. Sacco, G. Cormio, E. Breda, S. Cinieri, D. Natale and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload